Cleared Traditional

K223480 - Medipoint Blood Lancets (FDA 510(k) Clearance)

Jan 2023
Decision
56d
Days
Class 2
Risk

K223480 is an FDA 510(k) clearance for the Medipoint Blood Lancets. This device is classified as a Single Use Only Blood Lancet Without An Integral Sharps Injury Prevention Feature (Class II - Special Controls, product code QRK).

Submitted by Medipoint Holdings, LLC (Mineola, US). The FDA issued a Cleared decision on January 13, 2023, 56 days after receiving the submission on November 18, 2022.

This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 878.4850. A Disposable Blood Lancet Intended For A Single Use That Is Comprised Of A Single Use Blade Attached To A Solid, Nonreusable Base That Is Used To Puncture The Skin To Obtain A Drop Of Blood For Diagnostic Purposes..

Submission Details

510(k) Number K223480 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 18, 2022
Decision Date January 13, 2023
Days to Decision 56 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code QRK - Single Use Only Blood Lancet Without An Integral Sharps Injury Prevention Feature
Device Class Class II - Special Controls
CFR Regulation 21 CFR 878.4850
Definition A Disposable Blood Lancet Intended For A Single Use That Is Comprised Of A Single Use Blade Attached To A Solid, Nonreusable Base That Is Used To Puncture The Skin To Obtain A Drop Of Blood For Diagnostic Purposes.